Article
1p/19q testing has no significance in the workup of glioblastomas
31 Jan 2013
Abstract excerpt
AIMS: To determine whether testing for isolated 1p or 19q losses, or as a codeletion, has any significance in the workup of glioblastomas (GBMs). METHODS: Upfront 1p/19q testing by fluorescence in situ hybridization (FISH) and/or polymerase chain reaction (PCR)-based loss of heterozygosity (LOH) was done in 491 gliomas that were histologically diagnosed as GBMs. Outcomes were determined and measured against...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
